Artificial intelligence for inflammatory bowel disease dysplasia detection: Current evidence and future directions

doi:10.37126/aige.118493

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

(1)

(0)

(16)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

Artificial Intelligence in Gastrointestinal Endoscopy

ISSN

2689-7164

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

Artif Intell Gastrointest Endosc. Sep 8, 2026; 7(2): 118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493

Table 3 Ongoing/planned multicentre artificial intelligence-inflammatory bowel disease validation trials

Trial name	Design	Target condition	Sites	Status
Artificial intelligence in IBD-related dysplasia (AID) study[38]	Prospective	IBD dysplasia detection	Multicentre (Australia)	Recruiting
Artificial intelligence and dysplasia detection in inflammatory bowel disease (EIIDISIA study)[39]	Randomized clinical study	CADe vs Chromoendoscopy in IBD dysplasia detection	Multicentre (Spain)	Recruiting

Table 3 highlights several currently active and planned multicentre validation initiatives, such as artificial intelligence in inflammatory bowel disease-related dysplasia (AID study) artificial intelligence-and dysplasia detection in inflammatory bowel disease (EIIDISIA study), which implement many of the components of the proposed roadmap by recruiting a diverse set of inflammatory bowel disease patients and prospectively comparing the performance of artificial intelligence to that of expert clinicians. IBD: Inflammatory bowel disease; CADe: Computer-aided detection.

Full Size Table

Citation: Bhandari R, Gartlan J, Oppong P, Chhabra P. Artificial intelligence for inflammatory bowel disease dysplasia detection: Current evidence and future directions. Artif Intell Gastrointest Endosc 2026; 7(2): 118493
URL: https://www.wjgnet.com/2689-7164/full/v7/i2/118493.htm
DOI: https://dx.doi.org/10.37126/aige.118493

Bhandari R, Gartlan J, Oppong P, Chhabra P. Artificial intelligence for inflammatory bowel disease dysplasia detection: Current evidence and future directions. Artif Intell Gastrointest Endosc 2026; 7(2): 118493 [DOI: 10.37126/aige.118493]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.